ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $226 | -$61 | -$216 | -$168 |
| Dep. & Amort. | $16 | $6 | $2 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $67 | $66 | $68 | $64 |
| Change in WC | $4 | $18 | $38 | -$25 |
| Other Non-Cash | -$156 | -$12 | -$6 | $0 |
| Operating Cash Flow | $158 | $17 | -$114 | -$126 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$40 | $0 | -$1 |
| Net Acquisitions | $0 | -$32 | $0 | $70 |
| Inv. Purchases | -$505 | -$370 | -$363 | -$493 |
| Inv. Sales/Matur. | $329 | $442 | $436 | $423 |
| Other Inv. Act. | $147 | $32 | $0 | -$70 |
| Investing Cash Flow | -$31 | $32 | $73 | -$71 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7 | $25 | $8 | $18 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $7 | $25 | $8 | $18 |
| Forex Effect | -$0 | -$0 | $0 | $0 |
| Net Chg. in Cash | $134 | $74 | -$33 | -$179 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $194 | $115 | $153 | $332 |
| End Cash | $328 | $189 | $121 | $153 |
| Free Cash Flow | $157 | -$23 | -$114 | -$127 |